| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/11/2023 | 69.72% | Barrington Research | → $25 | Reiterates | Outperform → Outperform |
| 05/03/2023 | -11.74% | Stephens & Co. | → $13 | Reiterates | → Equal-Weight |
| 02/23/2023 | 69.72% | Barrington Research | → $25 | Reiterates | → Outperform |
| 02/22/2023 | -11.74% | Stephens & Co. | → $13 | Reiterates | → Equal-Weight |
| 01/09/2023 | 15.41% | B of A Securities | $23 → $17 | Downgrades | Buy → Underperform |
| 11/03/2022 | 49.36% | JP Morgan | $25 → $22 | Maintains | Overweight |
| 05/04/2022 | — | CJS Securities | Upgrades | Market Perform → Market Outperform | |
| 02/28/2022 | 35.78% | Northcoast Research | → $20 | Downgrades | Buy → Neutral |
| 02/25/2022 | — | Guggenheim | Upgrades | Sell → Neutral | |
| 05/21/2021 | — | B of A Securities | Upgrades | Neutral → Buy | |
| 02/18/2021 | 8.62% | Stephens & Co. | $23 → $16 | Downgrades | Overweight → Equal-Weight |
| 02/17/2021 | 28.99% | Truist Securities | $32 → $19 | Downgrades | Buy → Hold |
| 02/17/2021 | -25.32% | Guggenheim | → $11 | Downgrades | Neutral → Sell |
| 11/17/2020 | — | B of A Securities | Downgrades | Neutral → Underperform | |
| 10/01/2020 | — | Stephens & Co. | Upgrades | Equal-Weight → Overweight | |
| 08/13/2020 | 49.36% | Northcoast Research | → $22 | Upgrades | Neutral → Buy |
| 05/08/2020 | 1.83% | SunTrust Robinson Humphrey | $17 → $15 | Maintains | Buy |
| 04/23/2020 | 28.99% | JP Morgan | → $19 | Upgrades | Neutral → Overweight |
| 04/16/2020 | -11.74% | Stephens & Co. | $14 → $13 | Maintains | Equal-Weight |
| 03/23/2020 | -4.96% | Stephens & Co. | $22 → $14 | Maintains | Equal-Weight |
| 03/18/2020 | — | B of A Securities | Downgrades | Buy → Neutral | |
| 03/10/2020 | — | Guggenheim | Upgrades | Sell → Neutral | |
| 01/10/2020 | 62.93% | Jefferies | → $24 | Downgrades | Buy → Hold |
| 07/02/2019 | — | Guggenheim | Downgrades | Neutral → Sell | |
| 07/01/2019 | 103.67% | SunTrust Robinson Humphrey | $65 → $30 | Maintains | Buy |
| 07/01/2019 | — | JP Morgan | Downgrades | Overweight → Neutral |
What is the target price for Openlane (KAR)?
The latest price target for Openlane (NYSE: KAR) was reported by Barrington Research on August 11, 2023. The analyst firm set a price target for $25.00 expecting KAR to rise to within 12 months (a possible 69.72% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Openlane (KAR)?
The latest analyst rating for Openlane (NYSE: KAR) was provided by Barrington Research, and Openlane reiterated their outperform rating.
When is the next analyst rating going to be posted or updated for Openlane (KAR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Openlane, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Openlane was filed on August 11, 2023 so you should expect the next rating to be made available sometime around August 11, 2024.
Is the Analyst Rating Openlane (KAR) correct?
While ratings are subjective and will change, the latest Openlane (KAR) rating was a reiterated with a price target of $0.00 to $25.00. The current price Openlane (KAR) is trading at is $14.73, which is within the analyst's predicted range.